Melanoma Diagnostics Leader, Mela Sciences (MELA), Participates in Skin Cancer Diagnostic Workshop with Leading German Dermatologists, Hosted by Germany’s Augsburg Clinic
12/9/2013 7:06:47 AM
MELA Sciences, Inc. (NASDAQ:MELA), designer and developer of MelaFind®, an FDA and CE Mark approved non-invasive optical device that assists dermatologists in diagnosing melanoma at its most curable stage, participated in a two-day hands-on skin cancer diagnostics workshop in Augsburg, Germany, where leading dermatologists examined “high-risk” melanoma patients with MelaFind® and also participated in an imaging devices exhibit.
Help employers find you! Check out all the jobs and post your resume.
comments powered by